Gilead Sciences has grown revenue 3.6% a year over three years and 2.7% a year over five, with earnings per share compounding at 23%. Revenue growth, 3-year annual rate: +3.6% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +2.7%, growth has picked up over the last three years. Earnings per share, 3-year rate: +23%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

GILDGilead Sciences

Healthcare

$151.17+36% 1Y

$151.17

$108.5052 weeks$153.91

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−35.2 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.

Margin direction−35.2 points operating

Trailing-twelve-month operating margin, -7.0% now against 28.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is GILD growing?

Gilead Sciences has grown revenue 3.6% a year over three years and 2.7% a year over five, with earnings per share compounding at 23%.

+3.6%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +2.7%
Revenue growth, 5-year rate · +3.6% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +23%
Earnings per share, 3-year rate · revenue +3.6% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed